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Diabetic retinopathy is a preventable microvascular diabetic complication and a leading cause of vision loss. Retinal pigment
epithelial cell apoptosis is an early event in diabetic retinopathy. Taurine is reportedly beneﬁcial for diabetic retinopathy and is
abundant in the fruit of Lycium barbarum (LB). We have investigated the eﬀect of pure taurine and an extract of LB rich in taurine
on a model of diabetic retinopathy, the retinal ARPE-19 cell line exposed to high glucose. We demonstrate for the ﬁrst time that
LB extract and the active ligand, taurine, dose dependently enhance cell viability following high glucose treatment in the ARPE-
19 retinal epithelial cell line. This cytoprotective eﬀect was associated with the attenuation of high glucose-induced apoptosis,
which was shown by characteristic morphological staining and the dose-dependent decrease in the number of apoptotic cells,
determined by ﬂow cytometry. Moreover, we have shown that LB extract and taurine dose dependently downregulate caspase-3
proteinexpressionandtheenzymaticactivityofcaspase-3.Weconcludethattaurine,amajorcomponentofLB,andtheLBextract,
have a cytoprotective eﬀect against glucose exposure in a human retinal epithelial cell line and may provide useful approaches to
delaying diabetic retinopathy progression.
1.Introduction
Diabetic retinopathy (DR) is one of the most common
microvascularcomplicationsofdiabetesandremainsamajor
cause of preventable blindness worldwide [1]. Diabetes
damages all the major cells of the retina and pigment
epithelial cells [2]. This results in increased blood ﬂow and
capillary diameter, proliferation of the extracellular matrix
and thickening of basal membranes, altered cell turnover
(apoptosis, proliferation), and breakdown of the blood
retinal barrier [3].
Apoptosis or programmed cell death can be triggered
by various signals and is characterized by well-deﬁned
morphologic changes, including chromatin condensation
and fragmentation, and formation of apoptotic bodies [4].
Retinal microvascular cells are lost selectively via apoptosis
before other histopathology is detectable in diabetes [5].
Moreover, recent ﬁndings have suggested that apoptotic
episodes in retinal cells during the initial stage of diabetes
play an integral role in the early stage of vision loss [6].
Therefore, apoptosis is important in the progression and
pathogenesis of DR [7].
Retinal pigment epithelial (RPE) cells form a monolayer
between the neuroretina and the choriocapillaris, which are
the essential components of the outer blood retinal barrier
(BRB) that maintains physiological and structural balance
within the retina [8]. RPE cells are particularly susceptible
to oxidative stress because of high oxygen consumption by
photoreceptors[9].Moreover,recentstudieshaveshownthat
RPE cells undergo oxidative stress and UV-light induced
apoptosis [10, 11]. Although several studies have shown that
RPE degenerates in the early stage of diabetes [12, 13], the
mechanisms of high-glucose-induced apoptosis in RPE cell
models of DR are not fully understood.2 Evidence-Based Complementary and Alternative Medicine
High glucose causes activation of several proteins
involved in apoptotic cell death, including members of the
caspase family [14]. It is well known that caspases are
involved in the initiation and execution of apoptosis [15].
Moreover, the widely studied caspase-3 plays an important
role in diabetes [16].
Recent studies have suggested that ligand-activated
PPAR-γ controls apoptosis, contributing to tissue protection
[17]. Indeed, it has been shown that the PPAR-γ agonist
rosiglitazone protects against oxidative stress-induced apop-
tosisthroughupregulationofantiapoptoticBcl-2familypr o-
teins[18].Troglitazoneshowedacytoprotectiveactivityfrom
oxidative stress-induced apoptosis in ARPE-19 cells [19].
Moreover, the study has shown that a natural ligand, 15-
deoxy-delta-12,14-prostaglandin J2 (15d-PGJ2), helps RPE
cells to maintain mitochondrial integrity by prevention
of cytochrome c (cyt c) release from mitochondria and
subsequent activation of the apoptosis pathway [20].
Fruits from Lycium barbarum L. (LB) in the family
Solanaceae are a well-known traditional Chinese medicine
which has glucose-lowering activity and antiapoptotic activ-
ity [21]. There is a growing body of evidence indicating
that LB intake increases the fasting plasma zeaxanthin levels,
beneﬁcial for maintaining macular pigment density in age-
related macular degeneration [22]. Moreover, polysaccha-
rides of LB (LBP) increase antiapoptotic protein Bcl-2 levels
in lens epithelial cells [23]. LB contains 18 types of amino
acids, including taurine, a nonessential free amino acid,
which is one of the chemical components most abundant
in LB [24, 25]. Taurine has been recommended as a com-
plementary therapeutic agent for the prevention of diabetic
complications in type II diabetes [26]. Moreover, it has
been shown that taurine inhibits the activation of caspase-
3 in ischemic cardiomyocytes [27]. Taurine has also been
found to prevent high-glucose-mediated endothelial cell
apoptosis through its antioxidant property [28]. Recently,
we have shown that LB extract and pure taurine, a major
component in the LB extract, activated PPAR-γ by luciferase
reporter gene analysis and by mRNA and western blotting
measurement in human retinal pigment epithelial cells. At
the same time, both LB extract and pure taurine inhibited
a variety of PPAR-γ-dependent downstream eﬀectors in the
retinal cells [29]. However, the pathways of the beneﬁcial
eﬀect of LB and its taurine active component on DR
by modulation of high-glucose-induced apoptosis through
the PPAR-γ-mediated caspase-3 pathway have not been
investigated. Therefore, the aim of this study is to investigate
the cytoprotective eﬀect of pure taurine and an extract of LB
rich in taurine against glucose exposure in a human retinal
epithelial cell line as a model of DR.
2.MaterialsandMethods
2.1. Preparation of LB Extract. Dried LB was purchased in
raw powder form (batch no. 53101: DeDu Holdings, West
Ryde,Australia).ThepreparationofanextractofLBwasper-
formed as previously described [29, 30] with modiﬁcations.
Brieﬂy, 250mg of ﬁne LB powder was extracted with 2.5mL
of methanol by sonication at room temperature for 15min
followed by centrifugation for 5min. This step was repeated
four times. The solvent was then evaporated under reduced
pressure below 50◦C, and the remaining solid was collected.
The identiﬁcation and quantiﬁcation of taurine in the LB
extractwereundertakenbythinlayerchromatography(TLC)
analysis as previously described [29].
2.2.TissueCultureandTreatment. Thehumanretinalepithe-
lial cell line, ARPE-19, was provided by Dr. Weiyong Shen
(Save Sight Institute, Sydney, Australia). Cells were cul-
tured as previously described [31]. Brieﬂy, the cells were
cultured in a humidiﬁed incubator at 37◦Ci n5 %C O 2 in
10% fetal bovine serum-deﬁned minimal essential medium
(FBS-DMEM)-F12 medium) containing 5.5mM D-glucose,
supplemented with 100U/mL penicillin G and 100μg/mL
streptomycin. The culture medium was replaced with fresh
medium every second day. Upon conﬂuence, cultures were
passaged by dissociation in 0.05% (w/v) trypsin (Gibco-Life
Technologies, Roseville, MD, USA) in phosphate-buﬀered
saline (PBS) pH 7.4. For high-glucose-induced functional
studies, cells were maintained in fresh medium containing
1% FBS for 2h prior to use in the experiments. Cells
were then pretreated with samples, rosiglitazone (RG), 15-
deoxy-delta (12, 14)-prostaglandin J2 (PG), or vehicle (0.5%
DMSO) for 6h followed by further exposure to normal
(5.5mM) or high (33.3mM) D-glucose for 48h. Cells incu-
bated in 27.5mM mannitol (M) served as osmotic control
[32].
2.3. Cell Viability by MTS Assay. Cell proliferation was as-
sessed by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy
phenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay us-
ing the Cell Titer 96 AqueousOne Solution Cell Proliferation
Assay Kit (Promega, Madison, WI, USA), as previously
described with some modiﬁcations [33]. Brieﬂy, ARPE-19
cells were cultured in 96-well plates (3 × 104/mL). Upon
conﬂuence, cells were treated with vehicle (0.05% DMSO),
RG, colchicine (Colch), or samples for 24h, 48h, and 72h.
For high-glucose cytotoxicity experiments, the medium was
replaced with fresh medium containing 1% FBS for 2h prior
to use in the experiments. Cells were then preincubated with
treatment samples, RG, PG, or vehicle (0.5% DMSO) for 6h
followedbyexposuretonormal(5.5mM)orhigh(33.3mM)
D-glucose for a further 48h. On the day of the proliferation
assay, 20μL of the MTS solution was added to each of the
96 wells and incubated at 37◦C for 1h in a humidiﬁed (5%
CO2) environment. The absorbance at 490nm was read in
a microplate reader (Bio-Rad Laboratories, Inc, CA). The
percentage of cell proliferation was calculated as (OD of
treated samples/OD of untreated control) × 100.
2.4. Detection of Apoptotic Cells. Cells undergoing apoptosis
were determined by Hoechst 33342 staining and Annexin V
ﬂow cytometry analysis, as previously described with mod-
iﬁcations [4]. Brieﬂy, cells were ﬁxed in 4% formaldehyde
for 10min and stained with Hoechst dye for 10min. Cells
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(excitation at 365nm and emission at 480nm, using a UV
ﬁlter). A minimum of 300 cells in each cover slip, from six
randomly selected ﬁelds, were counted, and apoptotic cells
were expressed as percentage of total cells counts.
2.5. Quantiﬁcation of Apoptotic Cells. Apoptotic cells were
quantiﬁed by ﬂow cytometry using FITC Annexin V apop-
tosis detection kit (BD Biosciences, San Jose, USA), as previ-
ously described [34]. Brieﬂy, after appropriate treatments, 1
× 105 cells/100μL were collected, and 5μL of FITC Annexin
Va n d5μL of propidium iodide (PI) were added. Cells were
incubated in the dark at 25◦C. After 15min, 400μLo f1 x
bindingbuﬀerwasaddedtothecells.TheAnnexinV-positive
(+)/PI-negative (−) cells, indicating early apoptotic cells,
and the Annexin V-positive (+)/PI-positive (+), indicating
late apoptotic cells, were detected by FACSCalibur (BD
Biosciences, San Jose, USA). The results were analysed using
the WINDI 2.5 software. Annexin V-FITC conjugates were
detected at the FL1 channel, and PI was read on the FL3
channel.
2.6. Caspase-3 Activity Assay. Caspase-3 activity was mea-
sured by the caspase-3 ﬂuorometric assay system (BD Bio-
sciences, San Jose, USA), as previously described [35]w i t h
modiﬁcations. Brieﬂy, a total of 1 × 106 c e l l sw e r eh a r v e s t e d
and resuspended in cold cell lysis buﬀer (10mM Tris-HCL,
10mM NaH2PO4/NaHPO4 (pH7.5), 130mM NaCl, 1%
Triton-X-100, and 10mM sodium pyrophosphate (NaPPi))
for 30min on ice. Cell lysate protein concentrations were
determined by the BCA (bicinchoninic acid) assay (Thermo,
USA) according to the manufacturer’s instructions. Equal
amounts of protein were added to each well in a 96-well plate
containing 200μL of HEPES buﬀer and 5μL of the ﬂuoro-
genic substrate, DEVD-AMC (7-amino-4-methylcoumarin),
and incubated for 1h at 37◦C. Cleavage of the substrate
by active caspase-3 resulted in an increase of ﬂuorescence
(excitation = 380nm and emission = 460nm), measured
in a 96-well plate ﬂuorometer (FLUOstar OPTIMA), and
expressed as unit per milligram protein.
2.7. Protein Extraction and Semiquantitative Western Blot-
ting Analysis. Immunoblots were conducted as described
previously [36]. The proteins from the cells were prepared
using the Ripa lysis buﬀer (25mM Tris buﬀer (pH 7.6),
150mM NaCl, 1% NP-40, 1% sodium deoxycholate, and
0.1% SDS). The lysed cells were centrifuged at 12,000rpm
(Micromax RF centrifuge, Thermo IEC, MA, USA) for
10min and supernatants resolved by SDS-PAGE, 4–12%
(Invitrogen, Australia). Protein was transferred to cellulose
membrane in transfer buﬀer (Tris base 25mM, glycine
192mM, pH 8.3) and blocked in 5% skim milk powder
(Sigma-Aldrich, St. Louis, MO, USA) overnight. The pri-
mary antibodies (Santa Cruz Biotechnology, USA) were
anticaspase-3 rabbit polyclonal primary antibodies (1:500
dilution). After incubation with the primary antibody for
1hr at room temperature, the membrane was washed and
further incubated with horseradish peroxidase-conjugated
anti-mouse secondary antibodies (1:6000 dilution; Santa
Cruz Biotechnology, USA). Bound antibodies were detected
using enhanced chemiluminescence with Lumi-Light West-
ern Blotting Substrate (Roche). The membranes were
exposedtoX-rayﬁlm(Kodak,USA)anddevelopedusingthe
SRX-101A X-ray developer (Konica, Taiwan). The resultant
ﬁlmswerequantiﬁedbyscanningdensitometryusingImageJ
(National Institutes of Health, Bethesda, MD). Protein
expression was quantiﬁed by normalization to α-tubulin.
The membranes were reprobed with anti-α-tubulin primary
antibody (1:10,000 dilution; Santa Cruz Biotechnology,
USA) after stripping and overnight blotting with 5% skim
milk. The membranes were reincubated with horseradish
peroxidase-conjugated anti-mouse secondary antibody and
detected using the same procedure as described above. Cell
lysate protein concentrations were determined by the BCA
(bicinchoninic acid) assay (Thermo, USA) according to the
manufacturer’s instructions.
2.8. Chemicals. Rosiglitazone (RG) was purchased from
Alexis Biochemicals (San Diego, CA, USA). Pure taurine
compound, 15-deoxy-delta (12, 14)-prostaglandin J2(PG),
andotherchemicalswerepurchasedfromSigma-Aldrich(St.
Louis, MO, USA), unless otherwise indicated.
2.9. Statistical Analysis. All results are expressed as means ±
SEM Data were analysed by 1-factor analysis of variance
(ANOVA). If a statistically signiﬁcant eﬀect was found, the
Newman-Keuls test was performed to isolate the diﬀerence
between the groups. P values less than 0.05 (P<0.05) were
considered to indicate signiﬁcance.
3. Results
3.1.EﬀectofTaurineandLBExtractonCellViabilityinARPE-
19CellsCulturedinNormalGlucoseCondition. Todetermine
whether LB extract and taurine component inﬂuenced
viability in normal glucose-treated ARPE-19 cells, MTS
assay was performed for 24h, 48h, and 72h of incubation.
IncubationofLBextractat0.001,0.01,0.1,0.5,and1mg/mL
in normal glucose-treated APRE-19 cells for 24h and 48h
had little or no cytotoxicity (>90% viability remained). At
5mg/mL, LB extract was cytotoxic at all incubation times
(Figure 1(a)).
Incubation of APRE-19 cells with taurine for 24h, 48h,
and72hhadlittleornoeﬀectoncytotoxicity(>90%viability
remaining). At 5 and 10mM, taurine was slightly cytotoxic
(approximately 80% viability remaining) at all incubation
times (Figure 1(b)).
3.2. Cytoprotective Eﬀects of Taurine and LB Extract in ARPE-
19 Cells Exposed to High Glucose. As it is wellestablished that
hyperglycemia induces cell death in retinal epithelial cells
[37], ARPE-19 cells were treated with 33.3mM glucose for
48h in the presence of LB extract (0.1, 0.5, and 0.75mg/mL)
or taurine (0.001, 0.1, and 1mM), and their cytoprotective
eﬀect was examined by MTS assay. Since high glucose
increases osmolarity, ARPE-19 cells were also exposed to an
osmotic control (27.5mM mannitol + 5.5mM glucose). Cell4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Time- and dose-dependent eﬀect on cell viability following LB extract (a) and taurine (b) treatment. ARPE-19 cells were seeded
onto 96-well plates, and LB extract (0.001, 0.01, 0.1, 0.5, 1, and 5mg/mL) and taurine (0.001, 0.01, 0.1, 5, and 10mM) were added to the
medium for 24, 48, and 72h. Cell viability was measured by MTS assay. The values of cell viability were normalised to the value of the
control. The data represents the mean ± SEM of 5 independent experiments. Rosiglitazone (RG) served as positive control, and colchicine
(Colch) served as negative control.
viability in 33.3mM glucose was signiﬁcantly decreased by
59.9%; the loss of viability was reversed by adding LB extract
dosedependently(by67.9,74.4,and81.0%,resp.)(Figure 2).
Likewise cell viability in 33.3mM glucose condition was
reversed by adding taurine in a dose-dependent manner
(69.4, 82.6, and 89.3%, resp.) (Figure 2). Loss of cell viability
in high-glucose culture was similarly reversed by adding the
positive controls RG (by 73.8%) and PG (by 89.1%). The
osmotic control did not show a signiﬁcant reduction in cell
viability.
3.3. Eﬀect of Taurine and LB Extract on Cell Apoptosis in
High-Glucose-Treated ARPE-19 Cells. To investigate whether
the cytoprotective eﬀects of LB extract and taurine were
due to the attenuation of high-glucose-induced apoptosis,
characteristic morphological staining was performed using
Hoechst 33342 and ﬂow cytometry with Annexin V/PI
double staining to identify and quantify the apoptotic cells.
Incubation with high glucose for 48h induced a sig-
niﬁcant increase in the number of apoptotic cells (26.8%
of total cells), as identiﬁed by Hoechst staining, compared
with normal glucose culture (Figure 3(a)). The inhibitory
eﬀect of LB extract and taurine on high-glucose-induced
apoptosis was demonstrated in characteristic morphological
staining (Figure 3(b)). Treatment with LB extract (0.1, 0.5,
and 0.75mg/mL) dose dependently decreased the number
of apoptotic cells by 18.3, 15.0, and 8.7% of total cells,
respectively, compared to the high-glucose control, reaching
values comparable to those in the control cultures (5.2%
of total cells) (Figure 3(a)). Taurine (0.001, 0.1, and 1mM)
dosedependentlydecreasedthenumberofapoptoticcells,by
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Figure 2: Eﬀect of LB extract and taurine on high-glucose-induced
loss of cell viability. ARPE-19 cells pretreated with LB extract
(0.1, 0.5, and 0.75mg/mL) and taurine (0.001, 0.1, and 1mM)
were exposed to high glucose (33.3mM) for 48h. Cell viability
was determined by MTS assay. Results are expressed as percentage
of control and presented as mean ± SEM (n = 6 independent
experiments). #P<0.001 versus control; ∗P<0.05, ∗∗P<0.001
versus high glucose (HG). Mannitol (M) served as osmotic control.
14.0, 12.0, and 8.6% of total cells, respectively, compared to
the high-glucose control, approaching values in the control
cultures (5.2% of total cells) (Figure 3(a)). The number of
apoptotic cells as identiﬁed by Hoechst staining in high-
glucose condition was similarly decreased by the positive
controls RG (9.4%) and PG (7.6%).Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀect of LB extract and taurine on high-glucose-induced ARPE-19 cells, with condensed and/or fragmented chromatin
determined by the ﬂuorescent dye Hoechst 33342 method. (a) Quantiﬁcation of apoptotic cells in control and in high-glucose-induced
ARPE-19cellstreatedintheabsenceandpresenceofLBextract(0.1,0.5,and0.75mg/mL)ortaurine(0.001,0.1,and1mM)for48h.Positive
controls (RG and PG) and the osmotic control (M) were also used. The results are presented as percentage of total number of cells counted
(nonapoptotic + apoptotic) and represent the mean ± SEM (n = 6 independent experiments). ∗P<0.01 versus HG; #P<0.05 versus
control. (b) Morphological analysis of control (panel 1) and high-glucose-treated ARPE-19 cells with Hoechst staining. Arrows indicate
examples of cells with condensed and/or fragmented nuclei. Scale bar 50μm.6 Evidence-Based Complementary and Alternative Medicine
To further determine whether LB extract and taurine
decreased apoptosis in high-glucose-induced ARPE-19 cells,
apoptosis was measured as Annexin V binding to positive
cells and quantiﬁed by ﬂow cytometry, as Annexin V
binds speciﬁcally to PS, allowing the discrimination between
viable and apoptotic cells [38]. Representative dotplots of
control and treated high-glucose-induced ARPE-19 cells
stained with Annexin V and PI used for quantitation of
apoptosis are shown in Figure 4(b).L Be x t r a c t( 0 . 1 ,0 . 5 ,
and 0.75mg/mL) dose dependently decreased the number
of Annexin V positive cells (14.8, 10.2, and 6.4% of the
control) (Figure 4(a)). Taurine dose dependently decreased
the number of Annexin V-positive cells (14.8, 9.3, and 6.0%
of the control) (Figure 4(a)). The number of apoptotic cells
in high-glucose culture was decreased by adding the positive
controls,RG(by10.0%)andPG(6.1%).Theosmoticcontrol
did not enhance apoptotic cell death, excluding the involve-
ment of osmotic eﬀects of high-glucose concentrations.
3.4. Eﬀect of Taurine and LB Extract on Caspase-3 Pro-
tein Expression in High-Glucose-Treated ARPE-19 Cells. To
explore the mechanisms of the anti-apoptotic eﬀect of LB
extract, protein levels of active caspase-3 were examined by
western blot analysis. LB extract (0.1, 0.5, and 0.75mg/mL)
dose dependently downregulated caspase-3 protein expres-
sion (by 6.6-, 4.7-, and 2.7-fold, resp.) (Figure 5(a)).
Taurine (0.001, 0.1, and 1mM) dose dependently down-
regulatedcaspase-3proteinexpression(by7.0-,5.2-,and3.3-
f o l d ,r e s p . )( Figure 5(b)).
The protein levels of caspase-3 in high-glucose-treated
cells were decreased by adding the positive controls, RG (4.4-
fold)andPG(4.3-fold).Theosmoticcontroldidnotenhance
active caspase-3 protein level, excluding the involvement of
osmotic eﬀects of high-glucose concentrations.
3.5. Eﬀect of Taurine and LB Extract on Caspase-3 Activity
in High-Glucose-Induced ARPE-19 Cells. To conﬁrm the
ﬁndings of the downregulating eﬀect of LB extract and
taurine on apoptosis, activated caspase-3 in apoptotic cells
was determined by ﬂuorometric enzyme assay. LB extract
(0.1, 0.5, and 0.75mg/mL) dose dependently downregu-
lated caspase-3 activity (by 5.0-, 4.2-, and 3.9-fold, resp.)
(Figure 6).
Taurine (0.001, 0.1, and 1mM) dose dependently down-
regulatedcaspase-3activity(by5.7-,4.2-,and3.1-fold,resp.)
(Figure 6).
The activated caspase-3 levels in high-glucose condition
were reversed by adding the positive controls, RG (2.8-fold)
and PG (3.1-fold). The increased osmotic control did not
enhance active caspase-3 activity, excluding the involvement
of osmotic eﬀects of high-glucose concentrations.
4. Discussion
Diabetic retinopathy (DR) is a preventable microvascular
diabetic complication, and hyperglycemia is considered a
major factor in its development [39]. Although various
hyperglycemia-induced metabolic abnormalities are impli-
c a t e di nD R[ 40], it has been diﬃcult to pinpoint the exact
pathogenic mechanism, thus making the rationale for a
therapeutic target diﬃcult. The results of numerous studies
demonstrate that apoptosis is a critical part of the pathology
of DR [4, 6]. Apoptotic cell death in retinal regions is a
likely stimulus for the increased expression of molecules
that enhance the breakdown of the blood retinal barrier
(BRB) and lead to vascular proliferation [41]. Indeed, high-
glucose-induced apoptotic episodes have been demonstrated
by retinal abnormalities, potential visual changes, and the
onset of the ﬁrst vascular change [42].
RPE is essential for neuroretina survival and, conse-
quently, for visual function [43]. In response to damage
caused by hyperglycemic condition, RPE cells migrate and
proliferate, leading to a breakdown in adhesion between the
RPE and the choroidal capillaries, followed by BRB break-
down, compromising blood ﬂow within the RPE layer and
leading to eventual retinal edema [37]. In addition, studies
have shown that abnormalities in both the structural and
secretory functions of RPE cells, followed by photoreceptor
a p o p t o s i sa r ef o u n di nD R[ 43, 44].
An objective of the current study was to examine an
e x t r a c to fG o j ib e r r ya n di t sm a j o ra c t i v ec o m p o n e n to n
protection of retinal epithelial cell against glucose-induced
cytotoxicity as a model of diabetic retinopathy. Diabetes
results in various metabolic and biochemical abnormalities
in the retina, including increased oxidative stress, which has
been shown to induce the expression of the proapoptotic
molecules leading to apoptosis. Distinct members of the
caspase family are involved in both the initiation and
execution phases of apoptosis [45]. Among them, caspase-3
is the “executioner” caspase known to play an important role
in the proteolytic cascade during apoptosis [46]. Moreover,
the detection of activated caspase-3 is a very reliable tool to
identify cells destined to die by apoptosis [47].
Our previous work has established that Gogi berry
and its taurine component activate PPAR-γ [29]. PPAR-
γ is heterogeneously expressed in the mammalian eye,
prominently present in the retinal pigmented epithelium,
photoreceptor outer segments, and choriocapillaris [48]. A
recent study has shown that retinal expression of PPAR-γ
was suppressed in experimental models of diabetes and in
endothelial cells treated with high glucose [49]. Moreover,
recent studies have suggested that PPAR-γ ligands, including
15d-PGJ2 (PG) and rosiglitazone (RG), control apoptosis,
contributing to tissue protection [50, 51]. Moreover, a screen
of FDA-approved compounds identiﬁed RG as a novel anti-
apoptotic agent in retinal cells both in vivo and in vitro
[52]. Indeed, one recent study has shown that RG protects
oxidative stress-induced apoptosis through upregulation of
Bcl-2 and modulation of caspase-3 activation [17].
We have investigated the potential of Lycium barbarum
(LB) as a natural medicine for management of diabetic
retinopathy. LB is a traditional Chinese medicine used for
centuries in the east and is believed to be beneﬁcial for
eye-related pathology [53]. Diﬀerent biological activities
of LB have been demonstrated, including antiaging and
cytoprotection [54]. A recent study has shown that theEvidence-Based Complementary and Alternative Medicine 7
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Figure 6: Caspase-3 activity in high-glucose-treated ARPE-19 cells.
The eﬀect of LB extract and taurine on ﬂuorometrically determined
caspase-3 activity was measured in lysates of high-glucose-treated
ARPE-19 cells. The y-axis shows the amount of free 7-amino-
4-methylcoumarin (AMC) released from the caspase-3-speciﬁc
substrate DEVD (N-acetyl-Asp-Glu-Val-Asp)-AMC. Levels in the
control were arbitrarily assigned a value of 1.0. All values are means
± SEM (n = 4, each in duplicate). #P<0.001 versus control,
∗P<0.01, ∗∗P<0.001 versus HG.
aqueousextractofLBexhibitsneuroprotectiveeﬀectsagainst
β-amyloid peptide-induced apoptosis in cultured neurons
by attenuating the caspase-3-like activity [55]. Moreover, it
hasbeensuggestedthatLBpolysaccharides(LBPs)eﬀectively
protected the retina from neuronal death and apoptosis
by inhibiting proapoptotic signaling pathways, such as c-
Jun N-terminal protein kinase (JNK), dsRNA-dependent
protein kinase (PKR), and caspase-3 activity in retinal
ischemia/reperfusion injury, conﬁrming a neuroprotective
role in ocular diseases [56]. In addition, the study showed
anti-apoptotic activity of LBP in cultured seminiferous
epithelium against hyperthermia-induced damage through
the inhibition of superoxide-induced cyt c [57].
In parallel with the studies on LB extract, we have
investigated the eﬀect of taurine on apoptotic cytotoxicity
pathways in ARPE-19 cells. Taurine is one of the major
components in LB present in retina in abundance, where
it is essential for sustaining retinal structure and function
[25]. Various studies have shown that plasma and tissue
levels of taurine are reduced in diabetes [58–60]. Indeed,
studies have shown the beneﬁcial eﬀect of taurine sup-
plementation in preventing or ameliorating hyperglycemia-
induced retinal defects [58, 59]. Moreover, recent studies
have shown that diabetes or high-glucose-induced retinal
glial cell apoptosis is inhibited by taurine, exhibiting eﬀective
prevention against DR [61]. Anti-apoptotic action of taurine
has also been shown to occur by suppressing the Ca2+-
dependent mitochondrial permeability transition (mPT) to
prevent mitochondrial dysfunction and block activation of
the cyt c/caspase-3 apoptotic pathway in rat retinal ganglion
cells [62]. In addition, taurine exerts neuroprotective eﬀects
through an anti-apoptotic eﬀect by increasing Bcl-2 levels,
with a decrease in Bax and caspase-3 levels [15].
In previous work which formed the background leading
to the present studies, we determined that LB extract
and pure taurine, a major component in the LB extract,
activated PPAR-γ by luciferase reporter gene analysis and by
mRNA and western blotting measurement in human retinal
pigment epithelial cells. At the same time, both LB extract
and pure taurine inhibited a variety of PPAR-γ-dependent
downstream eﬀectors in the retinal cells [29]. In the presentEvidence-Based Complementary and Alternative Medicine 9
study, we hypothesised that taurine and the LB extract may
have a modulating eﬀect on high-glucose-induced apoptosis
through PPAR-γ-mediated caspase-3 pathway, responsible
for their eﬀects in DR. In order to test this hypothesis, we
ﬁrst investigated the eﬀect of taurine and LB extract on
modulating cell viability and therefore apoptosis in high-
glucose-treated ARPE-19 cells. Our results demonstrated
that a methanol extract of LB dose dependently overcame
the decreased cell viability in high-glucose-treated ARPE-19
cells (Figure 2). Taurine had a similar eﬀect on overcoming
decreasedcellviability(Figure 2).Thecytoprotectiveeﬀectof
taurine was associated with the attenuation of high-glucose-
induced apoptosis, which was shown by characteristic mor-
phological staining (Figure 3(b)) and Annexin V/PI double
staining (Figure 4(b)), and a dose dependent decrease in the
number of apoptotic cells (Figures 3(a) and 4(a)). Moreover,
the results have shown that taurine and the LB extract dose-
dependently downregulated caspase-3 protein expression
(Figures 5(a) and 5(b)) and inhibited the enzymatic activity
of caspase-3 (Figure 6). Therefore, the cytoprotective eﬀect
of LB extract parallels the profound suppression of high-
glucose-induced apoptosis at the site of caspase-3 regulation.
The eﬀects of taurine closely mimicked the eﬀects of the
methanolic LB extract, since they occurred at concentrations
0.001–1.00mM which we showed previously [29]w e r e
present in the range of methanolic extract used in the
treatments(0.1to0.75mg/mL).However,wecannotexclude
the possibility that other components may also contribute to
the cytoprotective eﬀects of LB.
In summary, this study has demonstrated for the ﬁrst
time that the traditional Chinese medicine Lycium barbarum
is cytoprotective against high-glucose cytotoxicity in retinal
pigment epithelial cells, at least in part by regulating
apoptosisasaresultofcaspase-3modulation.Thismayoccur
through the initial PPAR-γ activation found in previous
studies [29]. The eﬀects of the extract are closely mimicked
by taurine at concentrations present in the extracts. This
pathway and demonstration of its major active component
provide a rationale for the therapeutic use of taurine
and the valuable medicinal herb LB for the prevention
of DR. However, further investigation into their speciﬁc
mechanisms is warranted to gather proof of eﬃcacy and
safety of taurine and LB for protection against DR in various
preclinical and clinical settings.
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